Daniel Von Hoff
MD
Distinguished Professor, Physician-In-Chief
👥Biography 个人简介
Daniel Von Hoff led the MPACT trial establishing gemcitabine plus nab-paclitaxel as a standard therapy for metastatic pancreatic cancer, a regimen now widely used in neoadjuvant strategies. He is a pioneer of early phase trials at TGen. He continues to shape pancreatic cancer drug development.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Daniel Von Hoff 的研究动态
Follow Daniel Von Hoff's research updates
留下邮箱，当我们发布与 Daniel Von Hoff（Translational Genomics Research Institute (TGen)）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment